.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Fish and Richardson
Johnson and Johnson
Dow
UBS
US Department of Justice
AstraZeneca
McKesson
US Army

Generated: September 24, 2017

DrugPatentWatch Database Preview

LARODOPA Drug Profile

« Back to Dashboard

What is the patent landscape for Larodopa, and when can generic versions of Larodopa launch?

Larodopa is a drug marketed by Roche and is included in one NDA.

The generic ingredient in LARODOPA is levodopa. There are eighteen drug master file entries for this compound. Additional details are available on the levodopa profile page.

Summary for Tradename: LARODOPA

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list67
Clinical Trials: see list2
Patent Applications: see list8,450
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LARODOPA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
LARODOPA
levodopa
CAPSULE;ORAL016912-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
LARODOPA
levodopa
TABLET;ORAL016912-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
LARODOPA
levodopa
CAPSULE;ORAL016912-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
LARODOPA
levodopa
CAPSULE;ORAL016912-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
LARODOPA
levodopa
TABLET;ORAL016912-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche
LARODOPA
levodopa
TABLET;ORAL016912-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Merck
Moodys
Covington
Medtronic
McKesson
Queensland Health
Farmers Insurance
Citi
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot